Over half of healthcare organizations used AI in at least one business function in 2022. The global market for this technology reached $25.6 billion in 2023, yet a peer-reviewed study found algorithmic bias in three out of five common clinical AI tools. These figures illustrate the rapid adoption and significant challenges of medical AI.
Key Takeaways
- 58% of healthcare organizations reported using AI in at least one business function in 2022
- 33% of physicians report using AI tools in their day-to-day work (survey, 2023)
- The U.S. Bureau of Labor Statistics projects employment for medical and health services managers will increase by 28% from 2022 to 2032, supporting demand for AI-enabled clinical operations roles.
- $22.8 billion global market size for AI in healthcare in 2022 (MarketsandMarkets estimate)
- $15.5 billion global market size for AI in medical imaging in 2023 (2024 report estimate)
- $25.6 billion global market size for AI in healthcare in 2023 (2024 report estimate)
- $4.2 billion total funding for AI in healthcare startups in 2023 (Crunchbase/industry aggregation cited by PitchBook)
- $1.8 billion venture capital investment in healthcare AI in 2020 (industry recap)
- $499 million total amount awarded to healthcare AI/health data projects under the NIH Common Fund for FY2020–FY2024 (NLM/NIH program totals)
- 92.2% of AI/ML medical device submissions reviewed by FDA in 2022 were cleared (success rate reported in FDA summary)
- A 2019 study found that algorithmic bias occurred in at least 3 of 5 commonly used clinical AI tools tested across demographic groups (peer-reviewed finding)
- The FDA’s Total Product Life Cycle (TPLC) for AI/ML-enabled software supports premarket + postmarket performance monitoring (framework described in FDA guidance materials)
- In a 2020 NEJM paper, an AI system achieved 91.2% sensitivity for detecting pneumonia on chest radiographs (clinical performance metric)
- A 2022 study found an NLP system reduced time to extract key clinical information by 60% (time-savings metric)
- AI-enabled documentation tools reduced clinician documentation time by 30% in a controlled workplace study (productivity metric)
In 2022 healthcare adoption rose with AI, while market growth and improved clinical workflows accelerated rapidly.
Related reading
01 · Category
Industry Trends5 stats
01
58% of healthcare organizations reported using AI in at least one business function in 2022
02
33% of physicians report using AI tools in their day-to-day work (survey, 2023)
03
The U.S. Bureau of Labor Statistics projects employment for medical and health services managers will increase by 28% from 2022 to 2032, supporting demand for AI-enabled clinical operations roles.
04
AI-enabled medical devices accounted for 28% of all unique AI/ML-enabled device submissions in FDA’s Digital Health Center of Excellence data for FY2022–FY2023.
05
In a 2023 survey, 31% of healthcare organizations reported that their AI initiatives were funded through dedicated budgets (survey result, 2023).
Interpretation
Industry Trends Interpretation
Industry Trends show AI is moving from experimentation into mainstream adoption, with 58% of healthcare organizations using AI in at least one business function in 2022 and 31% funding AI initiatives through dedicated budgets in 2023.
02 · Category
Market Size7 stats
01
$22.8 billion global market size for AI in healthcare in 2022 (MarketsandMarkets estimate)
02
$15.5 billion global market size for AI in medical imaging in 2023 (2024 report estimate)
03
$25.6 billion global market size for AI in healthcare in 2023 (2024 report estimate)
04
$6.6 billion projected global market size for AI in clinical decision support by 2028 (2022–2023 forecast)
05
$3.2 billion projected global market size for medical AI in oncology by 2030 (2022 forecast)
06
An OECD report estimated that AI could increase global health spending productivity and generate measurable gains, with potential value linked to improved diagnostics and administrative efficiency (estimated productivity impact quantified in report).
07
The EU Commission’s 2024 AI Act estimates that the medical devices sector is among the highest-risk categories under the Act, driving compliance and validation costs for AI-based systems.
Interpretation
Market Size Interpretation
The AI in healthcare market is already sizable and accelerating, growing from an estimated $22.8 billion in 2022 to $25.6 billion in 2023, and with major segments like clinical decision support projected to reach $6.6 billion by 2028 this indicates sustained, expansion-driven market momentum in the medical AI category.
03 · Category
Investment & Funding3 stats
01
$4.2 billion total funding for AI in healthcare startups in 2023 (Crunchbase/industry aggregation cited by PitchBook)
02
$1.8 billion venture capital investment in healthcare AI in 2020 (industry recap)
03
$499 million total amount awarded to healthcare AI/health data projects under the NIH Common Fund for FY2020–FY2024 (NLM/NIH program totals)
Interpretation
Investment & Funding Interpretation
In the Investment and Funding landscape, healthcare AI attracted $4.2 billion in 2023 startup funding compared with $1.8 billion in 2020 venture investment, and while NIH Common Fund awards totaled $499 million for FY2020 through FY2024, private capital is clearly driving the surge in momentum.
04 · Category
Regulatory & Compliance1 stats
01
92.2% of AI/ML medical device submissions reviewed by FDA in 2022 were cleared (success rate reported in FDA summary)
Interpretation
Regulatory & Compliance Interpretation
In the regulatory and compliance space, the fact that 92.2% of FDA reviewed AI and ML medical device submissions were cleared in 2022 signals a strong approval rate and growing regulatory confidence in these technologies.
More related reading
05 · Category
Risk & Safety1 stats
01
A 2019 study found that algorithmic bias occurred in at least 3 of 5 commonly used clinical AI tools tested across demographic groups (peer-reviewed finding)
Interpretation
Risk & Safety Interpretation
A 2019 peer-reviewed study found that algorithmic bias showed up in at least 3 of 5 commonly used clinical AI tools across demographic groups, underscoring a major Risk and Safety concern for real-world medical deployments.
06 · Category
Performance Metrics8 stats
01
The FDA’s Total Product Life Cycle (TPLC) for AI/ML-enabled software supports premarket + postmarket performance monitoring (framework described in FDA guidance materials)
02
In a 2020 NEJM paper, an AI system achieved 91.2% sensitivity for detecting pneumonia on chest radiographs (clinical performance metric)
03
A 2022 study found an NLP system reduced time to extract key clinical information by 60% (time-savings metric)
04
A 2021 RCT reported that an AI-assisted triage system reduced emergency department length of stay by 14% (operational metric)
05
A 2020 retrospective study reported that AI-assisted readmission prediction reduced 30-day readmission risk by 2.2 percentage points in the intervention group (outcome metric)
06
In FDA’s MAUDE-based analysis of AI/ML medical device complaints, 39% of reported issues were related to performance/accuracy concerns (analysis period described in report).
07
A 2020 systematic review found that, across studies of clinical AI for radiology, pooled diagnostic performance (AUC) was commonly reported in the 0.80–0.90 range, with wide variability by study and dataset.
08
A 2023 multicenter evaluation of an AI model for diabetic retinopathy screening reported an F1 score of 0.91 when applied to real-world data.
Interpretation
Performance Metrics Interpretation
Performance metrics in AI healthcare show meaningful but variable clinical value, with diagnostic measures clustering around AUC 0.80 to 0.90 in radiology studies while specific applications report results such as 91.2% sensitivity for pneumonia detection and an F1 score of 0.91 for diabetic retinopathy in real-world data.
07 · Category
Cost Analysis8 stats
01
AI-enabled documentation tools reduced clinician documentation time by 30% in a controlled workplace study (productivity metric)
02
Hospitals using AI for revenue cycle management reported a 12% reduction in denials (operational metric from industry survey)
03
A 2022 study estimated that AI-driven imaging triage can reduce radiologist turnaround times by 40% (workflow metric)
04
A 2021 economic evaluation reported that AI-assisted risk stratification reduced avoidable care costs by 9% (cost metric)
05
A 2020 peer-reviewed study estimated that automated coding using AI reduced coding labor costs by $2.00per claim (cost metric)
06
A 2021 study in the Journal of the American Medical Informatics Association reported that AI-assisted administrative coding reduced coder time by 25% compared with baseline workflows.
07
A 2019 peer-reviewed study estimated that clinician time savings from AI documentation tools could translate to a net reduction of 2.3 work hours per physician per week in the modeled scenario.
08
A 2022 study reported that AI-based prior authorization management reduced average administrative turnaround time by 33% for participating payers/providers.
Interpretation
Cost Analysis Interpretation
Across cost analysis evidence, AI adoption is consistently trimming medical administrative and clinical expenses, with denials dropping 12%, radiology turnaround times falling 40%, and coding labor costs reduced by $2.00 per claim, alongside 30% less documentation time and a 9% reduction in avoidable care costs.
08 · Category
User Adoption3 stats
01
67% of healthcare organizations said they are piloting AI rather than fully deploying it (2023 survey result)
02
53% of respondents reported adopting AI for imaging/diagnostics use cases (2023 survey)
03
28% of respondents reported adopting AI for clinical decision support systems (2023 survey)
Interpretation
User Adoption Interpretation
In user adoption of AI in healthcare, most organizations are still in pilot mode with 67% not yet fully deploying, even though adoption is already highest for imaging and diagnostics where 53% report using it.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Daniel Varga. (2026, February 13). AI In The Medical Industry Statistics. Gitnux. https://gitnux.org/ai-in-the-medical-industry-statistics
MLA
Daniel Varga. "AI In The Medical Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/ai-in-the-medical-industry-statistics.
Chicago
Daniel Varga. 2026. "AI In The Medical Industry Statistics." Gitnux. https://gitnux.org/ai-in-the-medical-industry-statistics.
Sources & references
36 datasets cited across this report · attribution is report-level
+12 additional datasets cited (not shown individually)